However, the mRNA levels of the inhibitor of prostasin, PN-1 increase at both the transition between normal tissue and mild/moderate dysplasia and again at the transition between severe dysplasia and colorectal cancer. This evidence concerns the gene SERPINE2 and colorectal cancer.